FindTrial
Sign In

Efficacy of Limbal stem cell Transplantation in the management of severe chemical eye injury.

Autologous Simple Limbal Epithelial Transplantation in the management of Unilateral Total Limbal Stem Cell Deficiency due to severe chemical burn.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/11/037724
Enrollment
25
Registered
2021-11-01
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H183- Changes of corneal membranes Health Condition 2: H598- Other intraoperative and postprocedural complications and disorders of eye and adnexa, not elsewhere classified

Interventions

Intervention1: Autologous Simple Limbal Epithelial Transplantation (SLET): In this Surgical intervention trial, we will take 2 mm of limbal tissue( which harbours limbal stem cells ) from patients hea

Sponsors

SNMedical College Agra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Documented history of chemical burn Unilateral cases of chemical Burn

Exclusion criteria

Exclusion criteria: Unknown cases of LSCD B/L cases of LSCD Recurrent Pterygium and ocular surface tumor Active infection Disorganised Anterior Segment PL absent

Design outcomes

Primary

MeasureTime frame
Ocular surface stability(completely epithealized and avascular corneal surface) Post operative uncorrected visual acuityTimepoint: F/U on day1,day 7 ,day 15 post op day respectively and then monthly till the completion of study—

Secondary

MeasureTime frame
intra operative and post operative complicationsTimepoint: F/U on day1,day 7 ,day 15 post op day respectively and then monthly till the completion of study—

Countries

India

Contacts

Public ContactOshin Malhotra

S.N.Medical College Agra

shefalimazumdar@gmail.com9457288925

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026